Can a medical need clause help manage the growing costs of prescription drugs in the EU?

Health Economics, Policy, and Law
Eleanor Brooks, Robert Geyer

Abstract

Innovation in the development of new drugs has to balance the needs of health actors and administrators, the pharmaceutical industry and patients. Differing perspectives on what constitutes an innovation, where research and development should be directed and how new drugs should be evaluated and priced cause ongoing tensions within the regulatory framework. In the current climate, where Europe's health systems face rising demand for health services and increasingly restricted resources, the efficiency of pharmaceutical regulation and drug development is under even greater scrutiny. How can regulation foster innovation and industry growth while also serving the public health needs of society, and what is the EU's role in pursuing this objective? Drawing on a provision which formerly existed in Norwegian pharmaceutical legislation, this article explores the potential of a medical need clause (MNC) in addressing these issues. In restricting market authorisations to those drugs that offer an added therapeutic value, might a MNC foster innovation and spending efficiency in Europe's health systems?

References

May 1, 1995·Current Biology : CB·A Lumsden
Jul 5, 2005·BMJ : British Medical Journal·Lola Dare, Eric Buch
Sep 6, 2005·BMJ : British Medical Journal·Steven G MorganCharlyn D Black
Mar 8, 2007·Nature Medicine·Carl Nathan
Jun 26, 2007·Pharmacy World & Science : PWS·Jana DavidovaCecilia Stålsby Lundborg
Oct 26, 2007·Lancet·Silvio Garattini, Vittorio Bertele'
Jan 9, 2010·European Journal of Clinical Investigation·UNKNOWN Italian Medicines Agency (AIFA) Research & Development Working Group
Aug 30, 2011·European Journal of Health Law·A Mahalatchimy
Mar 24, 2012·Expert Opinion on Emerging Drugs·Isabelle StreuliCharles Chapron
Oct 15, 2013·BMJ : British Medical Journal·James Raftery
Jan 1, 2013·Journal of Pharmaceutical Policy and Practice·Zaheer-Ud-Din BabarCaroline Vaughan

❮ Previous
Next ❯

Citations

Dec 21, 2019·Journal of the Royal Society of Medicine·Livio Garattini, Anna Padula
Jul 22, 2018·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Livio Garattini, Anna Padula
Jul 23, 2019·The Milbank Quarterly·Bård Hobaek, Anne Kveim Lie

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.